Incidence of 'new-onset' constipation and associated factors during lockdown due to the COVID-19 pandemic.

Autor:	Remes-Troche JM; Instituto de Investigaciones Médico Biológicas, Universidad Veracruzana, Veracruz, Mexico jose.remes.troche@gmail.com., Coss-Adame E; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Departamento de Gastroenterologia, Mexico City, Mexico., Amieva-Balmori M; Instituto de Investigaciones Médico Biológicas, Universidad Veracruzana, Veracruz, Mexico., Velarde-Ruiz Velasco JA; Hospital Civil de Guadalajara Unidad Hospitalaria Fray Antonio Alcalde, Guadalajara, Mexico., Gómez-Castaños PC; UAS CIDOCS, Culiacan, Mexico., Flores-Rendón R; ISSSTECALI, Tijuana, Mexico., Gómez-Escudero O; Hospital Angeles Puebla, Puebla, Mexico., Rodríguez-Leal MC; IMSS UMAE No.25, Monterrey, Mexico., Durán-Rosas C; Instituto de Investigaciones Médico Biológicas, Universidad Veracruzana, Veracruz, Mexico., Pinto-Gálvez SM; Instituto de Investigaciones Médico Biológicas, Universidad Veracruzana, Veracruz, Mexico., Priego-Parra BA; Instituto de Investigaciones Médico Biológicas, Universidad Veracruzana, Veracruz, Mexico., Triana-Romero A; Instituto de Investigaciones Médico Biológicas, Universidad Veracruzana, Veracruz, Mexico.
Jazyk:	angličtina
Zdroj:	BMJ open gastroenterology [BMJ Open Gastroenterol] 2021 Sep; Vol. 8 (1).
DOI:	10.1136/bmjgast-2021-000729
Abstrakt:	Objective: A minimum of physical activity and low liquid intake are factors that have been associated with constipation. The health emergency brought on by the COVID-19 pandemic has resulted in adopting behaviour, such as sheltering-in-place (less mobility) and dietary changes, creating a scenario we believe to be an adequate model for examining the appearance of symptoms of constipation and its associated factors. Design: A cross-sectional and descriptive study was conducted on an open population, applying an electronic survey (4 weeks after lockdown due to COVID-19 in Mexico) to evaluate demographic characteristics, physical activity, water and fibre intake, appearance of constipation symptoms (including stool consistency), and quality of life. Results: Out of 678 subjects evaluated, 170 (25%, 95% CI: 21.7 to 28.4) developed symptoms of 'new-onset' constipation, with a significant decrease in the number of daily bowel movements (p<0.05) and stool consistency (p<0.05) during lockdown. Furthermore, in the 'new-onset' constipation population there was a higher proportion of subjects (79 (47%) of 170) who stopped exercising during the pandemic compared with the subjects who did not develop constipation symptoms (187 (37%) of 508, p=0.03, OR: 1.49, 95% CI: 1.0 to 2.1). The multivariate analysis (logistic regression) showed that female sex (p=0.001), water intake (p=0.039), and physical activity (p=0.012) were associated with 'new-onset' constipation. Conclusions: In our study on an open population in Mexico, we found that one-fourth of the population developed 'new-onset' constipation symptoms during the lockdown imposed due to the COVID-19 pandemic. A reduction of physical activity and less water consumption were associated factors. Competing Interests: Competing interests: JMR-T is a member of the advisory board of Takeda, Asofarma and Biocodex. He has been a speaker for Takeda, Asofarma, Medtronic, Carnot and Alfasigma. EC-A has been a speaker for Takeda, Asofarma, Medtronic, Carnot and Grünenthal. MA-B has been a speaker for Takeda and Asofarma. JAV-RV, PCG-C, RF-R, OG-E, MCR-L, CD-R, SMMP-G, BAP-P and ATR have no conflicts of interest. (© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu